Omada Health CAO logs option exercise and share sale
Omada Health, Inc. Chief Accounting Officer Craig Gracey filed an amended insider report detailing a same-day option exercise and share sale.
Rhea-AI Filing Summary
Omada Health, Inc. Chief Accounting Officer Craig Gracey filed an amended insider report detailing a same-day option exercise and share sale. Gracey exercised stock options to acquire 6,250 shares of common stock at $6.57 per share and sold 6,894 shares at a weighted average price of $17.4243 under a pre-arranged Rule 10b5-1 trading plan.
The amendment corrects an earlier filing that omitted the exercise leg of this exercise-and-sale transaction, which had caused reported post-transaction ownership to be understated. Following the transactions, Gracey directly holds 15,441 common shares and 43,750 stock options that remain outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Gracey Craig
Role
Chief Accounting Officer
Sold
6,894 shs ($120K)
Approx. gross sale proceeds
$120K
Approx. exercise cost
$41K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 6,250 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,250 | $6.57 | $41K |
| Sale | Common Stock | 6,894 | $17.4243 | $120K |
Holdings After Transaction:
Stock Option (Right to Buy) — 43,750 contracts (Direct);
Common Stock — 15,441 shares (Direct)
Footnotes (4)
- F1. This Form 4/A restates in its entirety the original Form 4 filed on 6/16/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F3. This transaction was executed in multiple trades at prices ranging from $17.04 to $17.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Shares sold: 6,894 shares
Weighted average sale price: $17.4243 per share
Options exercised: 6,250 shares
+5 more
8 metrics
Shares sold
6,894 shares
Common stock sale on June 12, 2026
Weighted average sale price
$17.4243 per share
Open-market sale on June 12, 2026
Options exercised
6,250 shares
Stock option exercise on June 12, 2026
Option exercise price
$6.57 per share
Stock Option (Right to Buy)
Shares held after sale
15,441 shares
Common stock directly owned after transactions
Options outstanding after exercise
43,750 options
Stock options remaining outstanding
Sale price range
$17.04–$17.71 per share
Multiple trades on June 12, 2026
Option expiration date
October 23, 2034
Stock Option (Right to Buy)
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), Vesting Commencement Date
4 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with 6,250 underlying shares of Common Stock."
Vesting Commencement Date financial
"25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date")."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Omada Health (OMDA) report for Craig Gracey?
Omada Health Chief Accounting Officer Craig Gracey exercised options for 6,250 shares at $6.57 and sold 6,894 common shares at a weighted average of $17.4243, as part of a same-day exercise-and-sale transaction disclosed in an amended Form 4/A filing.
Why did Craig Gracey file an amended Form 4/A for Omada Health (OMDA)?
The amended Form 4/A corrects an earlier report that omitted the option exercise underlying a same-day exercise-and-sale trade. That omission understated the number of securities beneficially owned after the sale, so the amendment updates post-transaction holdings in Box 5 to reflect the accurate amounts.
Was Craig Gracey’s Omada Health (OMDA) trade under a Rule 10b5-1 plan?
Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans pre-schedule trades, indicating this exercise-and-sale sequence was arranged in advance rather than being a discretionary response to short-term market movements.
What are the key terms of Craig Gracey’s Omada Health (OMDA) stock option?
The stock option covers 6,250 underlying shares at a $6.57 exercise price and expires on October 23, 2034. Twenty-five percent vested one year after the September 9, 2024 vesting commencement date, with the remainder vesting monthly so all shares vest by the fourth anniversary.
AI-generated analysis. How Rhea-AI works. Not financial advice.
